Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates

Listen Now

Topics Covered

• Overview of Diffuse Large B-Cell Lymphoma
• Staging & Grading
• Current Standard of Care
• Treatment Options for Resistant Disease
• New & Emerging Treatment Approaches
• The Role of Clinical Trials
• How Research Contributes to Treatment Choices
• Tips to Manage Treatment Side Effects, Symptoms, Discomfort & Pain
• The Increasing Role of Telehealth/Telemedicine Appointments
• Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Questions to Ask Our Panel of Experts

Our Panel of Experts

Catherine S M Diefenbach, MD

Associate Professor of Medicine, Translational Director of Hematology, Director of Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health

Erin Mulvey, MD

Assistant Professor of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine

Alexander P. Boardman, MD

Assistant Attending Physician, Department of Medicine, Lymphoma and Cellular Therapy Services, Memorial Sloan Kettering Cancer Center

Belita Cowan, MA

President, Lymphoma Foundation of America

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on May 08, 2025.